A detailed history of Hamilton Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Hamilton Capital, LLC holds 13,728 shares of ABT stock, worth $1.43 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,728
Previous 13,528 1.48%
Holding current value
$1.43 Million
Previous $1.49 Million 4.77%
% of portfolio
0.12%
Previous 0.12%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $21,904 - $24,192
200 Added 1.48%
13,728 $1.56 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $170,008 - $208,104
1,885 Added 16.19%
13,528 $1.49 Million
Q3 2023

Nov 15, 2023

SELL
$95.53 - $114.62 $18,055 - $21,663
-189 Reduced 1.6%
11,643 $1.13 Million
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $180,597 - $201,223
1,792 Added 17.85%
11,832 $1.29 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $129,695 - $152,659
-1,339 Reduced 11.77%
10,040 $1.02 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $165,024 - $193,598
1,736 Added 18.0%
11,379 $1.25 Million
Q3 2022

Nov 08, 2022

BUY
$96.76 - $112.03 $57,475 - $66,545
594 Added 6.56%
9,643 $933,000
Q2 2022

Aug 10, 2022

SELL
$102.07 - $123.37 $1,224 - $1,480
-12 Reduced 0.13%
9,049 $983,000
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $60,088 - $73,274
527 Added 6.18%
9,061 $1.07 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $48,753 - $59,696
422 Added 5.2%
8,534 $1.2 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $126,576 - $140,030
1,085 Added 15.44%
8,112 $958,000
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $14,599 - $17,185
-138 Reduced 1.93%
7,027 $815,000
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $46,365 - $54,625
-426 Reduced 5.61%
7,165 $859,000
Q4 2020

Feb 11, 2021

BUY
$105.0 - $114.42 $90,300 - $98,401
860 Added 12.78%
7,591 $831,000
Q3 2020

Nov 19, 2020

SELL
$91.64 - $111.29 $50,035 - $60,764
-546 Reduced 7.5%
6,731 $733,000
Q2 2020

Aug 10, 2020

BUY
$76.57 - $98.0 $21,209 - $27,146
277 Added 3.96%
7,277 $665,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $7,978 - $11,666
-127 Reduced 1.78%
7,000 $552,000
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $44,436 - $49,468
566 Added 8.63%
7,127 $619,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $25.1 Million - $27.2 Million
-306,470 Reduced 97.9%
6,561 $549,000
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $22.3 Million - $26 Million
306,093 Added 4411.83%
313,031 $26.3 Million
Q1 2019

May 10, 2019

BUY
$66.22 - $80.06 $8,873 - $10,728
134 Added 1.97%
6,938 $555,000
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $1,245 - $1,411
19 Added 0.28%
6,804 $511,000
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $12,770 - $15,405
210 Added 3.19%
6,785 $498,000
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $352,946 - $377,865
6,575
6,575 $375,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Hamilton Capital, LLC Portfolio

Follow Hamilton Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Capital, LLC with notifications on news.